These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 20187234)

  • 1. The nonmotor symptoms of Parkinson's disease--an overview.
    Lim SY; Lang AE
    Mov Disord; 2010; 25 Suppl 1():S123-30. PubMed ID: 20187234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact and management of nonmotor symptoms of Parkinson's disease.
    Lyons KE; Pahwa R
    Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and behavioural impairment in Parkinson's disease.
    Merims D; Freedman M
    Int Rev Psychiatry; 2008 Aug; 20(4):364-73. PubMed ID: 18925485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
    Gallagher DA; Goetz CG; Stebbins G; Lees AJ; Schrag A
    Mov Disord; 2012 Jan; 27(1):79-83. PubMed ID: 21915909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmotor manifestations of Parkinson's disease.
    Simuni T; Sethi K
    Ann Neurol; 2008 Dec; 64 Suppl 2():S65-80. PubMed ID: 19127582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current strategies in the treatment of Parkinson's disease and a personalized approach to management.
    Diaz NL; Waters CH
    Expert Rev Neurother; 2009 Dec; 9(12):1781-9. PubMed ID: 19951137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
    Merims D; Giladi N
    Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfaction and apathy in Parkinson's disease.
    Cramer CK; Friedman JH; Amick MM
    Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease--Part 2: Treatment of motor symptoms.
    Weintraub D; Comella CL; Horn S
    Am J Manag Care; 2008 Mar; 14(2 Suppl):S49-58. PubMed ID: 18402508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
    Chaudhuri KR; Martinez-Martin P; Schapira AH; Stocchi F; Sethi K; Odin P; Brown RG; Koller W; Barone P; MacPhee G; Kelly L; Rabey M; MacMahon D; Thomas S; Ondo W; Rye D; Forbes A; Tluk S; Dhawan V; Bowron A; Williams AJ; Olanow CW
    Mov Disord; 2006 Jul; 21(7):916-23. PubMed ID: 16547944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmotor symptom complex of Parkinson's disease--an under-recognized entity.
    Mehndiratta M; Garg RK; Pandey S
    J Assoc Physicians India; 2011 May; 59():302-8, 313. PubMed ID: 21751608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.
    Cubo E; Martín PM; Martin-Gonzalez JA; Rodríguez-Blázquez C; Kulisevsky J;
    Mov Disord; 2010 Jan; 25(1):70-5. PubMed ID: 20014110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the extranigral aspects of Parkinson disease.
    Lim SY; Fox SH; Lang AE
    Arch Neurol; 2009 Feb; 66(2):167-72. PubMed ID: 19204152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem.
    Sung VW; Nicholas AP
    Neurol Clin; 2013 Aug; 31(3 Suppl):S1-16. PubMed ID: 23931951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.